These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 31489763)
1. Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma. Zuo Y; Zhang L; Tang W; Tang W J Cell Mol Med; 2019 Nov; 23(11):7762-7772. PubMed ID: 31489763 [TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma. Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566 [TBL] [Abstract][Full Text] [Related]
4. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma. Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646 [TBL] [Abstract][Full Text] [Related]
5. Landscape analysis of alternative splicing in kidney renal clear cell carcinoma and their clinical significance. Cheng S; Zhou Z; Liu J; Li J; Wang Y; Xiao J; Luo Y Aging (Albany NY); 2024 Jun; 16(11):10016-10032. PubMed ID: 38862257 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma. Duan Y; Zhang D J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370 [TBL] [Abstract][Full Text] [Related]
7. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data. Zhang D; Zhang W; Sun R; Huang Z Bioengineered; 2021 Dec; 12(1):1091-1110. PubMed ID: 33783315 [TBL] [Abstract][Full Text] [Related]
8. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma. Chen L; Xiang Z; Chen X; Zhu X; Peng X Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362 [TBL] [Abstract][Full Text] [Related]
9. Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma. Wei Y; Zhang Z; Peng R; Sun Y; Zhang L; Liu H Comput Math Methods Med; 2021; 2021():5576933. PubMed ID: 33959190 [TBL] [Abstract][Full Text] [Related]
10. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma. Xing Q; Ji C; Zhu B; Cong R; Wang Y Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma. Gao L; He RQ; Huang ZG; Dang YW; Gu YY; Yan HB; Li SH; Chen G J Cancer; 2020; 11(6):1542-1554. PubMed ID: 32047561 [TBL] [Abstract][Full Text] [Related]
12. Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data. Ruan B; Feng X; Chen X; Dong Z; Wang Q; Xu K; Tian J; Liu J; Chen Z; Shi W; Wang M; Qian L; Ding Q Dis Markers; 2020; 2020():8824717. PubMed ID: 33110456 [TBL] [Abstract][Full Text] [Related]
13. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related]
15. Identification of genes and pathways involved in kidney renal clear cell carcinoma. Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354 [TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma. Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668 [TBL] [Abstract][Full Text] [Related]
17. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma. Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148 [TBL] [Abstract][Full Text] [Related]
18. Identifying the role of transient receptor potential channels (TRPs) in kidney renal clear cell carcinoma and their potential therapeutic significances using genomic and transcriptome analyses. Ren J; Yuan Q; Liu J; Zhong L; Li H; Wu G; Chen F; Tang Q BMC Med Genomics; 2022 Jul; 15(1):156. PubMed ID: 35831825 [TBL] [Abstract][Full Text] [Related]
19. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression. Xu L; He J; Cai Q; Li M; Pu X; Guo Y Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254 [TBL] [Abstract][Full Text] [Related]
20. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis. Hu F; Zeng W; Liu X Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]